禾元生物

688765 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

24.6B ($3.6B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

25.2M

Net Income

-151.0M

Gross Margin

N/A

Op. Margin

-6.0%

Net Margin

-6.0%

ROE

-25.1%

ROA

-14.2%

D/E

0.77

Dividend Yield

N/A

EPS

-0.56

Current Ratio

1.02

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 禾元生物

Wuhan Healthgen Biotechnology Corp. engages in the research and development of molecular pharmaceuticals in China. The company offers recombinant human serum albumin, proteins for cosmetics ingredients, and other recombinant proteins. It also provides recombinant growth factors, such as recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, recombinant human insulin-like growth factor-1 LR3, recombinant human vascular endothelial growth factor, recombinant human keratinocyte growth factor, recombinant human fibronectin, recombinant human a-1 antitrypsin, recombinant human lactoferrin, recombinant human epidermal growth factor, and recombinant human fibronectin. In addition, it provides recombinant protein expression, purification process development, and detection methodology services. The company was founded in 2006 and is based in Wuhan, China.

Ticker	688765
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业